Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 59 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 9724409

    Treatment of inflammatory skin disease

    XBIOTECH INC. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted

  2. US 9724350

    N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer

    Agios Pharmaceuticals, Inc. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted

  3. US 9725484

    Methods and compositions for the treatment of bone remodeling disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted

  4. US 9724387

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted

  5. US 9717679

    Methods for the prevention and treatment of animal skin conditions

    Touchless Designs LLC · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted

  6. US 9717710

    Treatment of mild and moderate Alzheimer's disease

    VTV THERAPEUTICS LLC · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted

  7. US 9717716

    Methods of sedation during critical care treatment

    OVID THERAPEUTICS INC. · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted

  8. US 9719080

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted

  9. US 9713612

    Compounds for treatment of cancer

    Curegenix, Inc. · Granted Jul 25, 2017 · Expires Jul 20, 2037

    granted

  10. US 9707206

    Mast cell stabilizers treatment for systemic disorders

    Patara Pharma, LLC · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  11. US 9707220

    Scopolamine for the treatment of depression and anxiety

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  12. US 9708371

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  13. US 9707284

    Formulations of peptides and chloroquines for the treatment of pathogenic immune responses in immune mediated diseases

    The Regents of the University of California · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  14. US 9700601

    Compositions and methods for the treatment of lysosomal storage disorders

    Regents of the University of Minnesota · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  15. US 9700578

    Use of nitrite salts for the treatment of cardiovascular conditions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  16. US 9701733

    Maspin-based treatment of cancer

    Northwestern University · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  17. US 9687481

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted

  18. US 9687527

    Stable glucagon formulations for the treatment of hypoglycemia

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted

  19. US 9687441

    Compositions for use with a fascia tissue treatment device to reduce cellulite

    Ashley Diana Black International Holdings, LLC · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted

  20. US 9683263

    Detection and treatment of irritable bowel syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

  21. US 9682116

    Date pit composition for the treatment of animals

    UNITED ARAB EMIRATES UNIVERSITY · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

  22. US 9682969

    Phthalazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

  23. US 9675615

    2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections

    The Board of Regents of the University of Texas System · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  24. US 9675637

    Use of nitrite salts for the treatment of cardiovascular conditions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.